Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.

Caanen MR, Schouten NE, Kuijper EAM, van Rijswijk J, van den Berg MH, van Dulmen-den Broeder E, Overbeek A, van Leeuwen FE, van Trotsenburg M, Lambalk CB.

Hum Reprod. 2017 May 13:1-8. doi: 10.1093/humrep/dex098. [Epub ahead of print]

PMID:
28505246
2.

Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: A systematic review.

Overbeek A, van den Berg MH, van Leeuwen FE, Kaspers GJ, Lambalk CB, van Dulmen-den Broeder E.

Cancer Treat Rev. 2017 Feb;53:10-24. doi: 10.1016/j.ctrv.2016.11.006. Epub 2016 Nov 24. Review.

PMID:
28056411
3.

Factors associated with frequency of discussion of or referral for counselling about fertility issues in female cancer patients.

Louwé LA, Stiggelbout AM, Overbeek A, Hilders CG, van den Berg MH, Wendel E, van Dulmen-den Broeder E, Ter Kuile MM.

Eur J Cancer Care (Engl). 2016 Oct 24. doi: 10.1111/ecc.12602. [Epub ahead of print]

PMID:
27774666
4.

A cluster randomized controlled trial on the effects and costs of advance care planning in elderly care: study protocol.

Korfage IJ, Rietjens JA, Overbeek A, Jabbarian LJ, Billekens P, Hammes BJ, Hansen-van der Meer E, Polinder S, Severijnen J, Swart SJ, Witkamp FE, van der Heide A.

BMC Geriatr. 2015 Jul 22;15:87. doi: 10.1186/s12877-015-0087-z.

5.

Fertility studies in female childhood cancer survivors: selecting appropriate comparison groups.

van den Berg M, van Dulmen-den Broeder E, Overbeek A, Ronckers C, van Dorp W, Kremer L, van den Heuvel-Eibrink M, Huizinga G, Loonen J, Versluys A, Bresters D, Lambalk C, Kaspers G, van Leeuwen F.

Reprod Biomed Online. 2014 Sep;29(3):352-61. doi: 10.1016/j.rbmo.2014.06.002. Epub 2014 Jun 12.

PMID:
25047538
6.

Practice, attitude and knowledge of Dutch paediatric oncologists regarding female fertility.

Overbeek A, van den Berg M, Louwé L, Wendel E, ter Kuile M, Kaspers G, Stiggelbout A, van Dulmen-Den Broeder E, Hilders C.

Neth J Med. 2014 Jun;72(5):264-70.

7.

Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.

König TE, van der Houwen LE, Overbeek A, Hendriks ML, Beutler-Beemsterboer SN, Kuchenbecker WK, Renckens CN, Bernardus RE, Schats R, Homburg R, Hompes PG, Lambalk CB.

Hum Reprod. 2013 Oct;28(10):2804-12. doi: 10.1093/humrep/det266. Epub 2013 Jul 9.

PMID:
23838159
8.

Validity of self-reported data on pregnancies for childhood cancer survivors: a comparison with data from a nationwide population-based registry.

Overbeek A, van den Berg MH, Hukkelhoven CW, Kremer LC, van den Heuvel-Eibrink MM, Tissing WJ, Loonen JJ, Versluys AB, Bresters D, Kaspers GJ, Lambalk CB, van Leeuwen FE, van Dulmen-den Broeder E; DCOG LATER/VEVO Study Group.

Hum Reprod. 2013 Mar;28(3):819-27. doi: 10.1093/humrep/des405. Epub 2012 Nov 21.

PMID:
23175500
9.

Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells.

García-Vallejo JJ, Ambrosini M, Overbeek A, van Riel WE, Bloem K, Unger WW, Chiodo F, Bolscher JG, Nazmi K, Kalay H, van Kooyk Y.

Mol Immunol. 2013 Apr;53(4):387-97. doi: 10.1016/j.molimm.2012.09.012. Epub 2012 Oct 24.

PMID:
23103377
10.

A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges.

Overbeek A, van den Berg MH, Kremer LC, van den Heuvel-Eibrink MM, Tissing WJ, Loonen JJ, Versluys B, Bresters D, Kaspers GJ, Lambalk CB, van Leeuwen FE, van Dulmen-den Broeder E; DCOG LATER-VEVO study group.

BMC Cancer. 2012 Aug 23;12:363. doi: 10.1186/1471-2407-12-363.

11.

Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis.

Overbeek A, Broekmans FJ, Hehenkamp WJ, Wijdeveld ME, van Disseldorp J, van Dulmen-den Broeder E, Lambalk CB.

Reprod Biomed Online. 2012 Jun;24(6):664-9. doi: 10.1016/j.rbmo.2012.02.023. Epub 2012 Mar 9.

PMID:
22503280
12.

Malignant melanoma as second malignant neoplasm in long-term childhood cancer survivors: a systematic review.

Braam KI, Overbeek A, Kaspers GJ, Ronckers CM, Schouten-van Meeteren AY, Van Dulmen-Den Broeder E, Veening MA.

Pediatr Blood Cancer. 2012 May;58(5):665-74. doi: 10.1002/pbc.24023. Epub 2012 Jan 9. Review.

PMID:
22232079
13.

Comment on: Li HW, Wong CY, Yeung WS, Ho PC, Ng EH. Serum anti-Mullerian hormone level is not altered in women using hormonal contraceptives. Contraception 2011;83:582-5.

van den Berg MH, Overbeek A, van Dulmen-den Broeder E, Lambalk CB.

Contraception. 2012 May;85(5):519-20; author reply 520-1. doi: 10.1016/j.contraception.2011.08.021. Epub 2011 Oct 11. No abstract available.

PMID:
22067749
14.

Using web-based and paper-based questionnaires for collecting data on fertility issues among female childhood cancer survivors: differences in response characteristics.

van den Berg MH, Overbeek A, van der Pal HJ, Versluys AB, Bresters D, van Leeuwen FE, Lambalk CB, Kaspers GJ, van Dulmen-den Broeder E.

J Med Internet Res. 2011 Sep 29;13(3):e76. doi: 10.2196/jmir.1707.

15.

Frequency distribution of polymorphisms in the FSH receptor gene in infertility patients of different ethnicity.

Kuijper EA, Blankenstein MA, Luttikhof LJ, Roek SJ, Overbeek A, Hompes PG, Twisk JW, Lambalk CB.

Reprod Biomed Online. 2011 Feb;22 Suppl 1:S60-5. doi: 10.1016/S1472-6483(11)60010-2.

PMID:
21575851
16.

Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.

van den Berg MH, van Dulmen-den Broeder E, Overbeek A, Twisk JW, Schats R, van Leeuwen FE, Kaspers GJ, Lambalk CB.

Hum Reprod. 2010 Jun;25(6):1520-7. doi: 10.1093/humrep/deq071. Epub 2010 Mar 27.

PMID:
20348556
17.

Frequency distribution of polymorphisms in the FSH receptor gene in infertility patients of different ethnicity.

Kuijper EA, Blankenstein MA, Luttikhof LJ, Roek SJ, Overbeek A, Hompes PG, Twisk JW, Lambalk CB.

Reprod Biomed Online. 2010 May;20(5):588-93. doi: 10.1016/j.rbmo.2010.02.004. Epub 2010 Feb 10.

PMID:
20223709
18.

Pharmacogenomics of ovulation induction: facilitating decisions on who, when and how to treat.

Overbeek A, Lambalk N.

Pharmacogenomics. 2009 Sep;10(9):1377-9. doi: 10.2217/pgs.09.110. No abstract available. Erratum in: Pharmacogenomics. 2009 Nov;10(11):1882.

19.

Phenotypic and pharmacogenetic aspects of ovulation induction in WHO II anovulatory women.

Overbeek A, Lambalk CB.

Gynecol Endocrinol. 2009 Apr;25(4):222-34. doi: 10.1080/09513590802571118. Review.

PMID:
19408171
20.

Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome.

Overbeek A, Kuijper EA, Hendriks ML, Blankenstein MA, Ketel IJ, Twisk JW, Hompes PG, Homburg R, Lambalk CB.

Hum Reprod. 2009 Aug;24(8):2007-13. doi: 10.1093/humrep/dep114. Epub 2009 Apr 28.

PMID:
19401323

Supplemental Content

Loading ...
Support Center